全文获取类型
收费全文 | 25040篇 |
免费 | 2312篇 |
国内免费 | 528篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 469篇 |
妇产科学 | 438篇 |
基础医学 | 2365篇 |
口腔科学 | 310篇 |
临床医学 | 3111篇 |
内科学 | 7044篇 |
皮肤病学 | 270篇 |
神经病学 | 2357篇 |
特种医学 | 586篇 |
外科学 | 2303篇 |
综合类 | 2167篇 |
现状与发展 | 4篇 |
预防医学 | 2415篇 |
眼科学 | 86篇 |
药学 | 2698篇 |
21篇 | |
中国医学 | 529篇 |
肿瘤学 | 627篇 |
出版年
2024年 | 31篇 |
2023年 | 763篇 |
2022年 | 853篇 |
2021年 | 1611篇 |
2020年 | 1630篇 |
2019年 | 1540篇 |
2018年 | 1371篇 |
2017年 | 1064篇 |
2016年 | 961篇 |
2015年 | 989篇 |
2014年 | 1715篇 |
2013年 | 2433篇 |
2012年 | 1206篇 |
2011年 | 1383篇 |
2010年 | 1024篇 |
2009年 | 1010篇 |
2008年 | 1073篇 |
2007年 | 1002篇 |
2006年 | 798篇 |
2005年 | 691篇 |
2004年 | 606篇 |
2003年 | 554篇 |
2002年 | 418篇 |
2001年 | 375篇 |
2000年 | 298篇 |
1999年 | 242篇 |
1998年 | 222篇 |
1997年 | 227篇 |
1996年 | 168篇 |
1995年 | 166篇 |
1994年 | 128篇 |
1993年 | 125篇 |
1992年 | 140篇 |
1991年 | 126篇 |
1990年 | 93篇 |
1989年 | 91篇 |
1988年 | 87篇 |
1987年 | 82篇 |
1986年 | 72篇 |
1985年 | 140篇 |
1984年 | 73篇 |
1983年 | 72篇 |
1982年 | 66篇 |
1981年 | 46篇 |
1980年 | 31篇 |
1979年 | 26篇 |
1978年 | 21篇 |
1977年 | 16篇 |
1975年 | 4篇 |
1974年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
《Research in social & administrative pharmacy》2022,18(8):3284-3289
BackgroundAdverse drug reactions (ADRs) and adverse drug events (ADEs) in older people contribute to a significant proportion of hospital admissions and are common following discharge. Effective interventions are therefore required to combat the growing burden of preventable ADRs. The Prediction of Hospitalisation due to Adverse Drug Reactions in Elderly Community Dwelling Patients (PADR-EC) score is a validated risk score developed to assess the risk of ADRs in people aged 65 years and older and has the potential to be utilised as part of an intervention to reduce ADRs.ObjectivesThis trial was designed to investigate the effectiveness of an intervention to reduce ADR incidence in older people and to obtain further information about ADRs and ADEs in the 12–24 months following hospital discharge.MethodsThe study is an open-label randomised-controlled trial to be conducted at the Royal Hobart Hospital, a 500-bed public hospital in Tasmania, Australia. Community-dwelling patients aged 65 years and older with an unplanned overnight admission to a general medical ward will be recruited. Following admission, the PADR-EC ADR score will be calculated by a research pharmacist, with the risk communicated to clinicians and discussed with participants. Following discharge, nominated general practitioners and community pharmacists will receive the risk score and related medication management advice to guide their ongoing care of the patient. Follow-up with participants will occur at 3 and 12 and 18 and 24 months to identify ADRs and ADEs. The primary outcome is moderate-severe ADRs at 12 months post-discharge, and will be analysed using the cumulative incidence proportion, survival analysis and Poisson regression.SummaryIt is hypothesised that the trial will reduce ADRs and ADEs in the intervention population. The study will also provide valuable data on post-discharge ADRs and ADEs up to 24 months post-discharge. 相似文献
2.
3.
4.
《Journal of Cardiovascular Computed Tomography》2022,16(6):483-490
BackgroundInflammation surrounding the coronary arteries can be non-invasively assessed using pericoronary adipose tissue attenuation (PCAT). While PCAT holds promise for further risk stratification of patients with low coronary artery disease (CAD) prevalence, its value in higher risk populations remains unknown.MethodsCORE320 enrolled patients referred for invasive coronary angiography with known or suspected CAD. Coronary computed tomography angiography (CCTA) images were collected for 381 patients for whom clinical outcomes were assessed 5 years after enrollment. Using semi-automated image analysis software, PCAT was obtained and normalized for the right coronary (RCA), left anterior descending (LAD), and left circumflex arteries (LCx). The association between PCAT and major adverse cardiovascular events (MACE) during follow up was assessed using Cox regression models.ResultsThirty-seven patients were excluded due to technical failure. For the remaining 344 patients, median age was 62 (interquartile range, 55–68) with 59% having ≥1 coronary artery stenosis of ≥50% by quantitative coronary angiography. Mean attenuation values for PCAT in RCA, LAD, and LCx were ?74.9, ?74.2, and ?71.2, respectively. Hazard ratios and 95% confidence intervals (CI) for normalized PCAT in the RCA, LAD, and LCx for MACE were 0.96 (CI: 0.75–1.22, p ?= ?0.71), 1.31 (95% CI: 0.96–1.78, p ?= ?0.09), and 0.98 (95% CI: 0.78–1.22, p ?= ?0.84), respectively. For death, stroke, or myocardial infarction only, hazard ratios were 0.68 (0.44–1.07), 0.85 (0.56–1.29), and 0.57 (0.41–0.80), respectively.ConclusionsIn patients referred for invasive coronary angiography with suspected CAD, PCAT did not predict MACE during long term follow up. Further studies are needed to understand the relationship of PCAT with CAD risk. 相似文献
5.
6.
7.
8.
9.
10.
《Revista espa?ola de cardiología》2022,75(12):1059-1069
Left ventricular noncompaction is a poorly defined and controversial entity, with wide phenotypic expression: from a simple anatomical trait to a disease with overt cardiac affection. Current diagnostic criteria rely exclusively on morphologic features of hypertrabeculation, which have low specificity for identifying true cardiomyopathy cases. The management of left ventricular noncompaction is also heterogeneous, and there are no dedicated clinical practice guidelines. The most common cardiovascular complications are heart failure, ventricular arrhythmias, and systemic embolisms. In this review, we discuss the diagnostic limitations of the available criteria, and propose a comprehensive alternative approach (including functional imaging variables, tissue characterization, genetics, and family screening) that may help in the differential diagnosis of hypertrabeculation cases. We also describe the genetic background of the disease and discuss the overlap with other cardiomyopathies. Finally, we focus on controversial issues in clinical management and suggest the use of the previously-mentioned variables for risk stratification and for individualization of patient follow-up. 相似文献